Answers are grounded in this paper and cite their sources.
Sepsis, a life-threatening organ dysfunction from a dysregulated infection response, remains a high-mortality global health burden characterized by the systemic overproduction of pro-inflammatory mediators and reactive oxygen and nitrogen species. Timely anti-infective/anti-inflammatory interventions in the early onset window drastically improve sepsis prognosis, yet current therapeutic efficacy remains severely constrained by the global antibiotic resistance crisis. As a two-dimensional nanomaterial, Ti3C2Tx MXene displays potent intrinsic antimicrobial and anti-inflammatory activities. We herein engineer a neutrophil membrane-coated Ti3C2Tx nanoplatform (NM@Ti3C2Tx NPs) for targeted sepsis therapy. Experimental validation confirms this formulation mitigates sepsis-triggered oxidative stress injury via synergistic antioxidant pathways, with favorable colloidal stability and confirmed in vitro biocompatibility. In CLP-induced murine sepsis models, it attenuates systemic pro-inflammatory cascades, alleviates hypothermia and multi-organ damage, and improves survival. Collectively, this multifunctional platform integrating targeted antibacterial action and oxidative stress modulation presents a promising candidate for sepsis translational therapy.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: